Director received an award of 1,146 GILD derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 30, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- May 4, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001629885-26-000002
- Filed / recorded
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerGILEAD SCIENCES, INC. Reporting personKelly A. Kramer SecurityRestricted Stock Unit TableDerivative (Table II) Transaction dateApr 30, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- 100% of the restricted stock units vested immediately upon the grant date of April 30, 2026.